These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19193626)

  • 1. Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer.
    Schäfer A; Fraccarollo D; Widder J; Eigenthaler M; Ertl G; Bauersachs J
    Eur J Heart Fail; 2009 Apr; 11(4):336-41. PubMed ID: 19193626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
    Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition.
    Schäfer A; Fraccarollo D; Hildemann S; Christ M; Eigenthaler M; Kobsar A; Walter U; Bauersachs J
    Thromb Haemost; 2003 Jun; 89(6):1024-30. PubMed ID: 12783115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
    Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Flierl U; Vogt C; Menninger S; Tas P; Ertl G; Bauersachs J
    Pharmacol Res; 2007 Sep; 56(3):217-23. PubMed ID: 17669665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure.
    Schäfer A; Fraccarollo D; Werner L; Bauersachs J
    Pharmacol Res; 2010 Nov; 62(5):432-8. PubMed ID: 20600916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure.
    Schäfer A; Fraccarollo D; Pförtsch S; Loch E; Neuser J; Vogt C; Bauersachs J
    Basic Res Cardiol; 2011 May; 106(3):485-94. PubMed ID: 21287353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation in heart failure.
    Schäfer A; Eigenthaler M; Bauersachs J
    Clin Lab; 2004; 50(9-10):559-66. PubMed ID: 15481631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats.
    Schäfer A; Widder J; Eigenthaler M; Ertl G; Bauersachs J
    Biochem Pharmacol; 2004 Jun; 67(12):2273-9. PubMed ID: 15163558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure, platelet activation and inhibition of the renin-angiotensin-aldosterone system.
    Bauersachs J; Schäfer A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):889-93. PubMed ID: 15521482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G.
    Kan WH; Hsu JT; Schwacha MG; Choudhry MA; Bland KI; Chaudry IH
    Ann Surg; 2008 Aug; 248(2):294-302. PubMed ID: 18650641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid regulation of platelet activation in vivo by nitric oxide.
    Schäfer A; Wiesmann F; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
    Circulation; 2004 Apr; 109(15):1819-22. PubMed ID: 15066953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet nitric oxide signalling in heart failure: role of oxidative stress.
    Shah A; Passacquale G; Gkaliagkousi E; Ritter J; Ferro A
    Cardiovasc Res; 2011 Sep; 91(4):625-31. PubMed ID: 21502370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
    J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nitric oxide donor pentaerythritol tetranitrate reduces platelet activation in congestive heart failure.
    Flierl U; Fraccarollo D; Widder JD; Micka J; Neuser J; Bauersachs J; Schäfer A
    PLoS One; 2015; 10(4):e0123621. PubMed ID: 25928879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung endothelial dysfunction in congestive heart failure: role of impaired Ca2+ signaling and cytoskeletal reorganization.
    Kerem A; Yin J; Kaestle SM; Hoffmann J; Schoene AM; Singh B; Kuppe H; Borst MM; Kuebler WM
    Circ Res; 2010 Apr; 106(6):1103-16. PubMed ID: 20167930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
    Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure.
    Dixon LJ; Morgan DR; Hughes SM; McGrath LT; El-Sherbeeny NA; Plumb RD; Devine A; Leahey W; Johnston GD; McVeigh GE
    Circulation; 2003 Apr; 107(13):1725-8. PubMed ID: 12665482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.